Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Novoseven

Known as: Novo Seven 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2007
Highly Cited
2007
The development of inhibitory antibodies to factor VIII is a serious complication of hemophilia. FEIBA (factor VIII inhibitor… Expand
  • table 1
  • table 2
  • table 3
  • table 4
  • figure 1
Is this relevant?
Review
2004
Review
2004
Background and Objectives  Recombinant activated factor VII (rFVIIa, NovoSeven™) has been used off‐label for various conditions… Expand
Is this relevant?
Highly Cited
2003
Highly Cited
2003
CARDIAC surgery with cardiopulmonary bypass (CPB) poses serious hemostatic challenges in Jehovah’s Witnesses, who refuse blood… Expand
Is this relevant?
Review
2000
Review
2000
  • U. Hedner
  • Blood coagulation & fibrinolysis : an…
  • 2000
  • Corpus ID: 25360198
&NA; Initiation of haemostasis involves the formation of a complex between tissue factor (TF) and activated factor VII (FVIIa… Expand
Is this relevant?
Highly Cited
2000
Highly Cited
2000
&NA; Recombinant activated factor VII (rFVIIa; NovoSeven®, Novo Nordisk A/S, Bagsvaerd, Denmark) is being increasingly used to… Expand
Is this relevant?
Highly Cited
2000
Highly Cited
2000
&NA; Recombinant activated factor VII (rFVIIa; NovoSeven®, Novo Nordisk A/S, Bagsvaerd, Denmark), used extensively for the… Expand
Is this relevant?
Highly Cited
1998
Highly Cited
1998
Recombinant factor VIIa (rFVIIa: NovoSeven; Novo Nordisk) has proven efficacy in the treatment of haemophilic patients with… Expand
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
Highly Cited
1998
Highly Cited
1998
Treatment of a Patient with Bernard-Soulier Syndrome and Recurrent Nosebleeds with Recombinant VIIa - 
Is this relevant?
Highly Cited
1998
Highly Cited
1998
Vitamin K antagonists are most commonly used in long-term thrombosis prophylaxis and the use in patients with cardiovascular… Expand
Is this relevant?
Highly Cited
1996
Highly Cited
1996
The concept of using factor VIIa (FVIIa) to induce hemostasis in hemophilia is new and takes advantage of the normal tissue… Expand
Is this relevant?